Financhill
Back

PDS Biotechnology Quote, Financials, Valuation and Earnings

PDS Biotechnology Price Quote

$2.26
-0.50 (-18.12%)
(Updated: November 14, 2024 at 5:55 PM ET)

PDS Biotechnology Key Stats

Sell
38
PDS Biotechnology (PDSB) is a Sell

Day range:
$1.53 - $2.36
52-week range:
$2.53 - $6.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.53%

Volume:
535.1K
Avg. volume:
345.4K
1-year change:
-47.48%
Market cap:
$109M
Revenue:
$0
EPS:
$-1.23

How Much Does PDS Biotechnology Make?

Data Unavailable

Is PDS Biotechnology Growing As A Company?

Data Unavailable

PDS Biotechnology Stock Price Performance

  • Did PDS Biotechnology Stock Go Up Last Month?
    PDS Biotechnology share price went down by -19.3% last month
  • Did PDSB's Share Price Rise Over The Last Year?
    PDSB share price fell by -47.48% over the past 1 year

What Is PDS Biotechnology 52-Week High & Low?

PDS Biotechnology Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy PDS Biotechnology?

  • How Much Debt Does PDS Biotechnology Have?
    Total long term debt quarterly is $0
  • How Much Cash Does PDS Biotechnology Have?
    Cash and short term investments quarterly total is $57.7M
  • What Is PDS Biotechnology’s Book Value Per Share?
    Book value per share is 0.84

Is PDS Biotechnology Cash Flow Positive?

  • What Is PDSB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$34.4M
  • What Is PDS Biotechnology’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $31.6M
  • What Is PDS Biotechnology’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

PDS Biotechnology Return On Invested Capital

Data Unavailable

PDS Biotechnology Earnings Date & Stock Price

PDS Biotechnology Competitors

  • Who Are PDS Biotechnology's Competitors?
    Below is a list of companies who compete with PDS Biotechnology or are related in some way:
    • Cellectar Biosciences Inc (CLRB)
    • Chimerix Inc (CMRX)
    • Jaguar Health Inc (JAGX)
    • Seres Therapeutics Inc (MCRB)
    • Marinus Pharmaceuticals Inc (MRNS)

PDS Biotechnology Dividend Yield

PDS Biotechnology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 29.59%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 12.40
Upside from Last Price: 349.28%

Major Shareholders

  • How many PDSB shares are owned by institutional investors?
    7.6M PDSB shares are owned by institutional investors
  • How many PDSB shares are owned by insiders?
    3M PDSB shares are owned by insiders